Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 61.97

-3.2%

9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: zeta1961 who wrote (14572)	12/8/2004 10:39:53 PM
From: Biomaven	Read Replies (1) of 52153

Zeta, One of the big advantages of a PIPE is that the company doesn't have to go through any of the rigamarole of a public offering - no quiet periods, no underwriters, etc. I'm not sure what a public offering runs these days in lawyer and underwriting fees, but I'm guessing well north of $500k for a small offering. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next